These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17395883)

  • 21. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
    Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
    Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic Expression of Niemann-Pick C1-Like 1, a Cholesterol Reabsorber from Bile, Exacerbates Western Diet-Induced Atherosclerosis in LDL Receptor Mutant Mice.
    Yamamoto H; Yamanashi Y; Takada T; Mu S; Tanaka Y; Komine T; Suzuki H
    Mol Pharmacol; 2019 Jul; 96(1):47-55. PubMed ID: 31064810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background.
    Hofmann A; Brunssen C; Poitz DM; Langbein H; Strasser RH; Henle T; Ravens U; Morawietz H
    Atheroscler Suppl; 2017 Nov; 30():294-302. PubMed ID: 29096854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.
    Flynn MC; Kraakman MJ; Tikellis C; Lee MKS; Hanssen NMJ; Kammoun HL; Pickering RJ; Dragoljevic D; Al-Sharea A; Barrett TJ; Hortle F; Byrne FL; Olzomer E; McCarthy DA; Schalkwijk CG; Forbes JM; Hoehn K; Makowski L; Lancaster GI; El-Osta A; Fisher EA; Goldberg IJ; Cooper ME; Nagareddy PR; Thomas MC; Murphy AJ
    Circ Res; 2020 Sep; 127(7):877-892. PubMed ID: 32564710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.
    Johansson F; Kramer F; Barnhart S; Kanter JE; Vaisar T; Merrill RD; Geng L; Oka K; Chan L; Chait A; Heinecke JW; Bornfeldt KE
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2082-7. PubMed ID: 18252823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.
    Zang M; Xu S; Maitland-Toolan KA; Zuccollo A; Hou X; Jiang B; Wierzbicki M; Verbeuren TJ; Cohen RA
    Diabetes; 2006 Aug; 55(8):2180-91. PubMed ID: 16873680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE
    Venegas-Pino DE; Lagrotteria A; Wang PW; Morphet J; Clapdorp C; Shi Y; Werstuck GH
    Atherosclerosis; 2018 Aug; 275():88-96. PubMed ID: 29879686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.
    Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
    Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
    PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice.
    MacDougall ED; Kramer F; Polinsky P; Barnhart S; Askari B; Johansson F; Varon R; Rosenfeld ME; Oka K; Chan L; Schwartz SM; Bornfeldt KE
    Am J Pathol; 2006 Jun; 168(6):2064-73. PubMed ID: 16723719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice.
    Nakatsu Y; Kokubo H; Bumdelger B; Yoshizumi M; Yamamotoya T; Matsunaga Y; Ueda K; Inoue Y; Inoue MK; Fujishiro M; Kushiyama A; Ono H; Sakoda H; Asano T
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG; Zhu Y; Coleman T; Semenkovich CF
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis.
    Fan Q; Yin X; Rababa'h A; Diaz Diaz A; Wijaya CS; Singh S; Suryavanshi SV; Vo HH; Saeed M; Zhang Y; McConnell BK
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H793-H810. PubMed ID: 31441691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis.
    Galle-Treger L; Moreau M; Ballaire R; Poupel L; Huby T; Sasso E; Troise F; Poti F; Lesnik P; Le Goff W; Gautier EL; Huby T
    Cardiovasc Res; 2020 Mar; 116(3):554-565. PubMed ID: 31119270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Roles of Endothelial Cell-Derived and Smooth Muscle Cell-Derived Fibronectin Containing Extra Domain A in Early and Late Atherosclerosis.
    Doddapattar P; Dev R; Jain M; Dhanesha N; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1738-1747. PubMed ID: 32434411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.
    Kanter JE; Kramer F; Barnhart S; Averill MM; Vivekanandan-Giri A; Vickery T; Li LO; Becker L; Yuan W; Chait A; Braun KR; Potter-Perigo S; Sanda S; Wight TN; Pennathur S; Serhan CN; Heinecke JW; Coleman RA; Bornfeldt KE
    Proc Natl Acad Sci U S A; 2012 Mar; 109(12):E715-24. PubMed ID: 22308341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remote Effects of Transplanted Perivascular Adipose Tissue on Endothelial Function and Atherosclerosis.
    Horimatsu T; Patel AS; Prasad R; Reid LE; Benson TW; Zarzour A; Ogbi M; Bruder do Nascimento T; Belin de Chantemele E; Stansfield BK; Lu XY; Kim HW; Weintraub NL
    Cardiovasc Drugs Ther; 2018 Oct; 32(5):503-510. PubMed ID: 30097828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis.
    Go GW
    Nutrients; 2015 Jun; 7(6):4453-64. PubMed ID: 26046396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice.
    Adingupu DD; Heinonen SE; Andréasson AC; Brusberg M; Ahnmark A; Behrendt M; Leighton B; Jönsson-Rylander AC
    J Diabetes Res; 2016; 2016():8630961. PubMed ID: 27774459
    [No Abstract]   [Full Text] [Related]  

  • 40. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.